IXHL → $2.40 by Sep 1, 2026.

My name is Dylan and I've been holding and researching IXHL (Incannex Healthcare Ltd) for close to a year. This is the most undervalued biotech setup and I want to break down exactly why. **First the number that should stop you in your tracks:** Incannex currently holds $75 million cash with absolutely zero debt. Their market cap is only $38 million. They also have an active $20 million share buyback program meaning the company itself is buying back its own …